Global Cancer Tissue Diagnostics Market Size By Type of Disease, By Final User, By Application, By Geographic Scope And Forecast
Report ID: 380755|No. of Pages: 202
Global Cancer Tissue Diagnostics Market Size By Type of Disease, By Final User, By Application, By Geographic Scope And Forecast
Cancer Tissue Diagnostics Market Size And Forecast
Cancer Tissue Diagnostics Market size was valued at USD 56.71 Billion in 2023 and is projected to reach USD 83.27 Billion by 2030, growing at a CAGR of 9.4% during the forecast period 2024-2030.
Global Cancer Tissue Diagnostics Market Drivers
The growth and development of the Cancer Tissue Diagnostics Market is attributed to certain main market drivers. These factors have a big impact on how Cancer Tissue Diagnostics are demanded and adopted in different sectors. Several of the major market forces are as follows:
- Growing Cancer prevalence and Prevalence: One major factor driving the need for cancer tissue diagnostics is the increased prevalence of different types of cancer worldwide. Accurate and timely diagnostic techniques are in more demand as cancer rates rise.
- Developments in Diagnostic Technologies: As a result of ongoing improvements in the sensitivity, specificity, and accuracy of cancer tissue diagnostics, the market is expected to grow. Examples of these technologies include immunohistochemistry (IHC), in situ hybridization (ISH), next-generation sequencing (NGS), and molecular diagnostics.
- Rise of Personalized Medicine: By identifying certain biomarkers, genetic mutations, and molecular profiles in tumors, cancer tissue diagnostics contribute significantly to personalized medicine. This helps pick focused therapies, which in turn drives market demand.
- Growing Stress on Early Detection: A cancer patient’s prognosis depends heavily on early detection. Diagnostics using cancer tissue can identify tumors accurately and early, which improves prognosis and treatment options.
- Rise in Biopsy operations: The need for effective and precise tissue diagnostic tools and assays is driven by the rising number of biopsy operations carried out for cancer diagnosis and treatment monitoring.
- Growing Elderly Population: The incidence of cancer tends to rise with global population aging. The need for cancer tissue diagnostics is increasing due in part to the aging population, especially for age-related malignancies.
- Raising Awareness and Screenings: People are prompted to conduct diagnostic tests by government initiatives, coordinated screening programs, and enhanced awareness campaigns for various malignancies. This is driving up demand for tissue diagnostics.
- Technological Advancements in Biomarker Discovery: To increase the uptake of cancer tissue diagnostics, ongoing research and development projects concentrate on finding novel biomarkers and targets linked to certain tumors.
- Growing Healthcare Expenditure: The market for cancer tissue diagnostics is expected to rise as a result of the increased expenditure in healthcare infrastructure, especially in emerging economies where access to cutting-edge diagnostic methods is improved.
- Demand for Companion Diagnostics: The adoption of cancer tissue diagnostics in conjunction with targeted therapies is driven by the need for companion diagnostics, which allow the best course of treatment to be chosen for a patient’s unique genetic composition.
Global Cancer Tissue Diagnostics Market Restraints
The Cancer Tissue Diagnostics Market has a lot of room to grow, but there are several industry limitations that could make it harder for it to do so. It’s imperative that industry stakeholders comprehend these difficulties. Among the significant market limitations are:
- Exorbitant Cost of Diagnostic Tests: Modern cancer tissue diagnostic techniques, such as sequencing technologies and molecular testing, are frequently associated with exorbitant costs, which restrict patient and healthcare facility accessibility and affordability.
- Regulatory and Reimbursement Difficulties: Tight regulatory approval procedures and complicated reimbursement procedures for innovative diagnostic tests can impede market expansion and postpone the release and uptake of new diagnostic technologies.
- Restricted Access to Advanced Healthcare: The adoption of sophisticated cancer tissue diagnostic technologies is hampered by unequal access to advanced healthcare facilities, particularly in rural or developing areas. This creates market barriers.
- Biomarker Identification Challenges: Finding distinct and clinically relevant biomarkers for every form of cancer is a difficult task that restricts the creation of diagnostic tests aimed at uncommon or less prevalent cancers.
- Interpretation and Standardization Problems: Adoption of cancer tissue diagnostics may be impacted by discrepancies in the interpretation and standardization of test results throughout laboratories or diagnostic platforms.
- Technology Limitations: Despite developments, some technology constraints in diagnostic instruments’ sensitivity, specificity, and detection thresholds can hinder their accuracy in analyzing cancer tissue, which could hinder market growth.
- Ethical and Privacy Issues: Questions about the appropriate use of patient tissue samples, data privacy, and informed consent for genetic testing in the diagnosis of cancer may create moral conundrums and restrict the growth of the market.
- Complexity of Data Analysis: There may be difficulties in analyzing, interpreting, and integrating massive amounts of complicated data produced by cutting-edge diagnostic methods like next-generation sequencing (NGS) into clinical practice.
- Training and Infrastructure Gaps: The expansion of the market may be hampered by inadequate training and a shortage of qualified personnel who can operate and interpret the findings of complex cancer tissue testing equipment.
- COVID-19 Impact: The COVID-19 pandemic that is still running strong has caused delays in cancer diagnosis, treatment, and research. As a result, the use and expansion of cancer tissue diagnostics have been impacted.
Global Cancer Tissue Diagnostics Market Segmentation Analysis
The Global Cancer Tissue Diagnostics Market is Segmented on the basis of Type of Disease, Final User, Application, and Geography.
Cancer Tissue Diagnostics Market, By Type of Disease
- Breast Cancer: Diagnostic instruments made especially for the study of breast cancer tissue.
- Lung Cancer: Molecular profiling is one of the diagnostic tools for lung cancer.
- Colorectal Cancer: Colorectal cancer tissue analysis-specific diagnostic solutions.
- Prostate Cancer: Instruments for tissue sample analysis and diagnosis.
- Others: This includes cancer diagnostics for ovarian, liver, and pancreatic cancers, among other cancer types.
Cancer Tissue Diagnostics Market, By The Final User
- Hospitals and Clinics: Cancer tissue analysis is performed in these venues using diagnostic instruments.
- Diagnostic Laboratories: Dedicated facilities providing diagnostic services for cancer tissue.
- Research Institutes: Resources for cancer research utilized by academic and research institutes.
- Contract Research Organizations (CROs): Thease are companies that offer diagnostic services for research and clinical trials.
Cancer Tissue Diagnostics Market, By Application
- Diagnostics: Instruments used to make tissue-analysis-based cancer diagnoses.
- Prognostics: Determining the probable path and result of cancer by examining the properties of the tissue.
- Companion Diagnostics: Instruments that support the use of tissue biomarkers to select individualized therapies.
Cancer Tissue Diagnostics Market, By Geography
- North America
- Europe, Asia-Pacific
- Latin America
- Middle East, and Africa
Key Players
The major players in the Cancer Tissue Diagnostics Market are:
- Roche Holding AG (Switzerland)
- Abbott Laboratories (US)
- Thermo Fisher Scientific, Inc. (US)
- Danaher Corporation (US)
- Siemens Healthineers AG (Germany)
- Agilent Technologies, Inc. (US)
- Illumina, Inc. (US)
- PerkinElmer, Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Leica Biosystems GmbH (Germany)
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2020-2030 |
| Base Year | 2023 |
| Forecast Period | 2024-2030 |
| Historical Period | 2020-2022 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Roche Holding AG (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Siemens Healthineers AG (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), PerkinElmer, Inc. (US). |
| Segments Covered | By Type of Disease, By The Final User, By Application, By Geography |
| Customization scope | Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Top Trending Reports:
Global Electronic Detonator Control Chip Market Size And Forecast
Global Electrical Wiring Interconnection System (EWIS) Market Size And Forecast
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team At Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as a future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1. Introduction
• Market Definition
• Market Segmentation
• Research Methodology
2. Executive Summary
• Key Findings
• Market Overview
• Market Highlights
3. Market Overview
• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter’s Five Forces Analysis
4. Cancer Tissue Diagnostics Market, By Type of Disease
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Others
5. Cancer Tissue Diagnostics Market, By The Final User
• Hospitals and Clinics
• Diagnostic Laboratories
• Research Institutes
•Contract Research Organizations (CROs)
6. Cancer Tissue Diagnostics Market, By Application
• Diagnostics
• Prognostics
• Companion Diagnostics
7. Regional Analysis
• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE
8. Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market
9. Competitive Landscape
• Key Players
• Market Share Analysis
10. Company Profiles
• Roche Holding AG (Switzerland)
• Abbott Laboratories (US)
• Thermo Fisher Scientific, Inc. (US)
• Danaher Corporation (US)
• Siemens Healthineers AG (Germany)
• Agilent Technologies, Inc. (US)
• Illumina, Inc. (US)
• PerkinElmer, Inc. (US)
• Bio-Rad Laboratories, Inc. (US)
• Leica Biosystems GmbH (Germany)
11. Market Outlook and Opportunities
• Emerging Technologies
• Future Market Trends
• Investment Opportunities
12. Appendix
• List of Abbreviations
• Sources and References
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
